<DOC>
	<DOCNO>NCT00226109</DOCNO>
	<brief_summary>Chronic alcoholic suffer weak skeletal cardiac muscle . The investigator discover beneficial effect spironolactone-treatment regard . Therefore , double blind placebo control study conduct , examine effect spironolactone cardiac skeletal muscle-function chronic alcoholic .</brief_summary>
	<brief_title>Clinical Trial Studying Effects Spironolactone Heart Skeletal Muscle Function Chronic Alcoholics</brief_title>
	<detailed_description>Our department do research skeletal muscle function patient liver cirrhosis . Post-hoc analyse one study suggest treatment spironolactone positive effect muscle strength endurance . This effect probably cause increase concentration Na , K-pumps ( sodium-potassium pump ) enable muscle cell perform good . To verify find design double-blinded , placebo-controlled , randomized clinical trial skeletal muscle strength , -endurance , Na , K-pump content , cardiac systolic , diastolic function primary endpoint . Spironolactone test placebo 40 participant include among admitted out-clinic patient . Muscle function-tests , muscle biopsy trans-thoracic echocardiography perform 12 week treatment .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Cardiomyopathy , Alcoholic</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Alcoholism , male gender Spironolactone treatment Tense ascites Hepatic encephalopathy Dementia Cancer Severe psychiatric disease Untreated thyroid disease Maltreated diabetes Spironolactone contraindication Kidney failure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>skeletal muscle</keyword>
	<keyword>spironolactone</keyword>
	<keyword>Na , K-pumps</keyword>
	<keyword>Magnesium</keyword>
</DOC>